These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 24062344)

  • 1. Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease.
    Kano O; Ikeda K; Iwasaki Y; Jiang H
    Neurology; 2013 Sep; 81(13):1181-2. PubMed ID: 24062344
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased iron levels in the temporal cortex in postmortem human brains with Parkinson disease.
    Yu X; Du T; Song N; He Q; Shen Y; Jiang H; Xie J
    Neurology; 2013 Jan; 80(5):492-5. PubMed ID: 23303856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Author response.
    Jiang H
    Neurology; 2013 Sep; 81(13):1182. PubMed ID: 24191353
    [No Abstract]   [Full Text] [Related]  

  • 4. Temporal lobe atrophy on MRI in Parkinson disease with dementia: a comparison with Alzheimer disease and dementia with Lewy bodies.
    Tam CW; Burton EJ; McKeith IG; Burn DJ; O'Brien JT
    Neurology; 2005 Mar; 64(5):861-5. PubMed ID: 15753423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bid signal pathway components are identified in the temporal cortex with Parkinson disease.
    Jiang H; He P; Adler CH; Shill H; Beach TG; Li R; Shen Y
    Neurology; 2012 Oct; 79(17):1767-73. PubMed ID: 23019260
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lewy body-related alpha-synucleinopathy in the aged human brain.
    Jellinger KA
    J Neural Transm (Vienna); 2004 Oct; 111(10-11):1219-35. PubMed ID: 15480835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accumulation of amyloid-β in the cerebellar cortex of essential tremor patients.
    Béliveau E; Tremblay C; Aubry-Lafontaine É; Paris-Robidas S; Delay C; Robinson C; Ferguson L; Rajput AH; Rajput A; Calon F
    Neurobiol Dis; 2015 Oct; 82():397-408. PubMed ID: 26253607
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased levels of BDNF protein in Alzheimer temporal cortex are independent of BDNF polymorphisms.
    Lee J; Fukumoto H; Orne J; Klucken J; Raju S; Vanderburg CR; Irizarry MC; Hyman BT; Ingelsson M
    Exp Neurol; 2005 Jul; 194(1):91-6. PubMed ID: 15899246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular expression of alpha7 nicotinic acetylcholine receptor protein in the temporal cortex in Alzheimer's and Parkinson's disease--a stereological approach.
    Banerjee C; Nyengaard JR; Wevers A; de Vos RA; Jansen Steur EN; Lindstrom J; Pilz K; Nowacki S; Bloch W; Schröder H
    Neurobiol Dis; 2000 Dec; 7(6 Pt B):666-72. PubMed ID: 11114264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coordinated expression of caspase 8, 3 and 7 mRNA in temporal cortex of Alzheimer disease: relationship to formic acid extractable abeta42 levels.
    Matsui T; Ramasamy K; Ingelsson M; Fukumoto H; Conrad C; Frosch MP; Irizarry MC; Yuan J; Hyman BT
    J Neuropathol Exp Neurol; 2006 May; 65(5):508-15. PubMed ID: 16772874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β.
    Palmer JC; Barker R; Kehoe PG; Love S
    J Alzheimers Dis; 2012; 29(4):853-61. PubMed ID: 22330820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mouse brains deficient in H-ferritin have normal iron concentration but a protein profile of iron deficiency and increased evidence of oxidative stress.
    Thompson K; Menzies S; Muckenthaler M; Torti FM; Wood T; Torti SV; Hentze MW; Beard J; Connor J
    J Neurosci Res; 2003 Jan; 71(1):46-63. PubMed ID: 12478613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anterior temporal atrophy and posterior progression in patients with Parkinson's disease.
    Potgieser AR; van der Hoorn A; Meppelink AM; Teune LK; Koerts J; de Jong BM
    Neurodegener Dis; 2014; 14(3):125-32. PubMed ID: 25138823
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered DARPP-32 expression in the superior temporal gyrus in schizophrenia.
    Kunii Y; Yabe H; Wada A; Yang Q; Nishiura K; Niwa S
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Jun; 35(4):1139-43. PubMed ID: 21453742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Midbrain iron content in early Parkinson disease: a potential biomarker of disease status.
    Martin WR; Wieler M; Gee M
    Neurology; 2008 Apr; 70(16 Pt 2):1411-7. PubMed ID: 18172063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased 5-HT2A receptors in the temporal cortex of parkinsonian patients with visual hallucinations.
    Huot P; Johnston TH; Darr T; Hazrati LN; Visanji NP; Pires D; Brotchie JM; Fox SH
    Mov Disord; 2010 Jul; 25(10):1399-408. PubMed ID: 20629135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diffuse Lewy body disease: an autopsy case.
    Kuroda S; Otsuki S; Hayashi Y
    Acta Med Okayama; 1987 Jun; 41(3):133-9. PubMed ID: 2820201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between α-synuclein and tau in Parkinson's disease comment on Wills et al.: elevated tauopathy and α-synuclein pathology in postmortem Parkinson's disease brains with and without dementia. Exp Neurol 2010; 225: 210-218.
    Jellinger KA
    Exp Neurol; 2011 Jan; 227(1):13-8. PubMed ID: 20965169
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Laminar degeneration of frontal and temporal cortex in Parkinson disease dementia.
    Armstrong RA
    Neurol Sci; 2017 Apr; 38(4):667-671. PubMed ID: 28181068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.